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Background: Endovascular treatment of ruptured abdominal aortic aneurysms (r-AAAs) has the potential to offer
improved outcomes. As our experience with endovascular repair of r-AAA evolved, we recognized that the development
of abdominal compartment syndrome (ACS) led to an increase in morbidity and mortality. We therefore reviewed our
experience to identify risk factors associated with the development of ACS.
Methods: From January 2002 to December 2004, 30 patients underwent emergent endovascular repair of r-AAA by using
commercially available stent grafts. All patients who developed ACS underwent emergent laparotomy. Physiological and
clinical parameters were analyzed between patients with and without ACS after endovascular r-AAA repair.
Results: Over the past 3 years, 30 patients underwent endovascular r-AAA repair, and 6 (20%) patients developed ACS.
Patients with ACS had a higher incidence of the need for aortic occlusion balloon (67% vs 12%; P  .01), a markedly
longer activated partial thromboplastin time (128  84 seconds vs 49  31 seconds; P  .01), a greater need for blood
transfusion (8  2.5 units vs 1.8  1.7 units; P  .08), and a higher incidence of conversion to aortouni-iliac devices
because of ongoing hemodynamic instability and an inability to expeditiously cannulate the contralateral gate (67% vs 8%)
when compared with patients without ACS. The mortality was significantly higher in the patients with ACS (67%; 4 of
6) compared with patients without ACS (13%; 3 of 24; P  .01).
Conclusions: ACS is a potential complication of endovascular repair of r-AAA and negatively affects survival. Factors
associated with the development of ACS include (1) use of an aortic occlusion balloon, (2) coagulopathy, (3) massive
transfusion requirements, and (4) conversion of bifurcated stent grafts into aortouni-iliac devices. We recommend that,
after endovascular repair of r-AAA, these patients undergo vigilant monitoring for the development of ACS. (J Vasc Surg
2005;42:1047–51.)Ruptured abdominal aortic aneurysms (r-AAA) con-
tinue to present a significant clinical challenge. Of patients
who survive to undergo open surgical repair, mortality rates
remain high, varying from 30% to 70%.1-4 Endovascular
aneurysm repair (EVAR) of r-AAA is feasible and offers the
potential for decreased morbidity and mortality.5-8 With
the evolution of endovascular techniques for treating
r-AAA, there is an increased recognition of new complica-
tions, such as the abdominal compartment syndrome
(ACS).5,6 Large retroperitoneal hematoma and diffuse vis-
ceral edema may contribute to ACS after EVAR of r-AAA.
The resulting intra-abdominal hypertension leads to respi-
ratory, cardiac, and renal dysfunction and is associated with
significant morbidity and mortality.9,10 Successful treat-
ment depends on early recognition and surgical decom-
pression.11-13
As our experience with EVAR of r-AAA evolved, we
recognized that the development of ACS was associated
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experience to identify risk factors associated with the devel-
opment of ACS in patients undergoing EVAR of r-AAA.
METHODS
From January 2002 to December of 2004, 56 patients
presented to our institution with r-AAA. Of these, 30
(54%) underwent EVAR and 26 (46%) underwent open
repair (Fig 1). The decision to perform EVAR or open
surgical repair was at the discretion of the vascular surgeon
on call. All patients with r-AAA were considered for EVAR
except when a pre-existing computed tomographic (CT)
scan indicated unsuitable morphology for endovascular
treatment and when the on-call surgeon was not comfort-
able performing EVAR in emergent settings. Preoperative
CT scans, when unavailable from referring institutions,
were obtained only in hemodynamically stable patients.
Patients with the clinical diagnosis of r-AAA, when hemo-
dynamically unstable, were taken directly to the operating
roomwithout preoperative CT. The technique of hypoten-
sive hemostasis was used in all patients, and resuscitation
was limited to maintaining a detectable blood pressure to
help minimize ongoing hemorrhage.5,6 We accept any
reduction in arterial systolic blood pressure (as low as 50
mm Hg) and restrict all fluid resuscitation as long as the
patients remain conscious and are able to talk and move.
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gency room on admission, and their blood pressures before
hospitalization did not influence our decision to obtain a
preoperative CT scan.
The procedures were performed in the operating room
with either general endotracheal (94%) or local anesthesia
(6%) at the discretion of the operative surgeon and the
anesthesiologist. All procedures were performed via bilat-
eral femoral cut-down. Our use of heparin in endovascular
treatment of r-AAA has evolved. We do not heparinize
patients with r-AAA undergoing open surgical repair. Early
in our experience with EVAR for r-AAA, we did give
heparin (50 U/kg intravenously) because of concerns re-
garding thrombotic complications related to the use of
high-profile endovascular devices. As our experience in-
creased, we recognized coagulopathy as a potential factor
associated with the development of ACS after EVAR for
r-AAA and stopped using heparin during these procedures.
Approximately half of the patients in our series received
heparin during EVAR. A supraceliac aortic occlusion bal-
loon was placed via a femoral or brachial approach only in
hemodynamically unstable patients. Currently available
Food and Drug Administration–approved stent grafts
(AneuRX [Medtronic, Santa Rosa, Calif], Excluder [Gore,
Flagstaff, Ari], and Zenith [Cook, Bloomington, Ind])
were used in accordance with an institutional review board
protocol. Devices were selected at the discretion of the
operative surgeon according to the anatomic requirements
of each patient. In patients with hemodynamic instability or
anatomic limitations that precluded expeditious exclusion
of the r-AAA, modular bifurcated stent grafts were con-
verted to aortouni-iliac (AUI) devices by deploying an
aortic cuff across the flow divider. The contralateral iliac
artery was interrupted by open ligation via the groin inci-
sion, endoluminal occlusion, or placement of a covered
stent from the internal iliac artery into the external iliac
artery, and femorofemoral bypass was performed.
ACS was diagnosed on the basis of established clinical
criteria, including tense abdominal distention, ongoing
oliguria, increased central venous pressures, increased pul-
monary capillary wedge pressures, decreased cardiac out-
put, increased peak airway pressures, and increased bladder
pressure (25 mm Hg).9-10,14,15 Patients diagnosed with
ACS underwent immediate abdominal decompression via
Total Rupture AAA 
N=56 
Open Surgical Repair 
N=26 (46%)
Endovascular Repair 
N=30 (54%)
ACS 
N=6 (20%)
No ACS 
N=24 (80%)
Fig 1. Total ruptured abdominal aortic aneurysms (AAA) subdi-
vided into the type of repair and the development of abdominal
compartment syndrome (ACS).midline laparotomy and temporary abdominal closure withthe use of sterile plastic bags to bridge the fascial defect and
prevent evisceration.16
Data on patients undergoing EVAR of r-AAA were
gathered prospectively and maintained in a vascular registry
for retrospective review. Information regarding patient de-
mographics, comorbidities, intraoperative findings, type of
stent graft used, and postoperative complications was re-
corded on all patients. A retrospective analysis was per-
formed to explore associations between ACS and poten-
tially influential variables related to patient demographics,
comorbidities, operative statistics, and diagnostic parame-
ters. The dichotomized outcome variable was the presence
of ACS in all r-AAA patients treated within the time of the
study. Dichotomous variables considered to be potentially
associated with this outcome were sex, diabetes, smoking
history, coronary artery disease, hypertension, pulmonary
disease, renal disease, and the need to perform aortic occlu-
sion during surgery. Continuous variables potentially asso-
ciated with ASC examined were age (in years), operating
room time (in minutes), time to cannulation of the con-
tralateral gate (in minutes), packed red blood cells (units
administered), and partial thromboplastin time (in sec-
onds). Logistic regression was used to individually assess
the association of these potential predictor variables with
ACS. The odds ratios are reported with their 95% confi-
dence interval in Table I.
RESULTS
From January 2002 to December of 2004, 30 patients
underwent emergent EVAR of r-AAA, and 6 patients (20%)
developed ACS that necessitated abdominal decompres-
sion via laparotomy. Twenty-one (70%) of the 30 patients
with r-AAA had a preoperative CT scan, and the remaining
9 (30%) patients were taken directly to the operating room
without any preoperative imaging because of hemody-
namic instability. Of the six patients with ACS, three (50%)
patients did not have a preoperative CT scan. The results of
univariate analysis are summarized in Table I. A compari-
son of patients with and without ACS after EVAR of r-AAA
revealed no significant difference in mean age (75 vs 72
years) or sex. Furthermore, there was no significant differ-
ence in the frequency of coronary disease (66% vs 74%),
hypertension (50% vs 82%), pulmonary disease (0% vs 39%),
diabetes (17% vs 21%), renal insufficiency (17% vs 9%), or
smoking (33% vs 25%).
The mean operative time from skin incision to closure
for patients with and without ACS was similar (89  30
minutes vs 92  20 minutes; P  not significant). Al-
though patients who developed ACS required an increased
volume of crystalloids in the perioperative period (ACS, 8.7
L; no ACS, 7.1 L), this difference was not statistically
significant. However, patients with ACS had a higher inci-
dence of the need for an aortic occlusion balloon (67% vs
12%; P  .01), a markedly longer activated partial throm-
boplastin time (128 84 seconds vs 49 31 seconds; P
.013), a greater need for blood transfusion (8 2.5 units vs
21.7 units; P  .08), and a higher incidence of conver-
sion to AUI devices because of ongoing hemodynamic
acked
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contralateral gate (67% vs 8%) when compared with pa-
tients without ACS.
The overall mortality rate for patients undergoing
EVAR of r-AAA (n 30) was 23%. Patients with ACS had
a significantly higher mortality (67%) when compared with
those without ACS (13%; P  .01). Multisystem organ
failure was the cause of death in all cases. The two survivors
with ACS had considerable postoperative morbidity. One
patient developed renal failure necessitating permanent
dialysis and required multiple operations for abdominal
closure. The second patient developed ischemic colitis ne-
cessitating colectomy and required prolonged ventilation
with tracheostomy. Both patients were alive and doing well
at 13months of follow-up. Of the 21 survivors in the group
without ACS, postoperative complications included myo-
cardial infarction (n  1), renal failure (n  1), respiratory
failure (n  1), prolonged ileus (n  2)), colonic ischemia
necessitating colectomy (n  1), distal ischemia (n  1),
wound infection (n  1), and cholecystitis (n  2). The
mean length of stay in this group was 14 days. All 21
patients were alive and well at a mean follow-up of 14
months (range, 3-29 months).
Four (67%) of the six patients who developed ACS
required conversion of modular bifurcated stent grafts to
AUI devices because of ongoing hemodynamic instability
and an inability to expeditiously cannulate the contralateral
gate (Table II). Of the 24 patients who did not develop
ACS, only 2 (8%) required conversion to AUI devices. One
patient had an aortoiliac aneurysm with rupture of the iliac
component; this necessitated open ligation of the internal
and external iliac arteries on the involved side. The second
patient had tortuous iliac anatomy that prevented passage
of the contralateral limb. The remainder of the patients
with AUI devices underwent embolization of the internal
iliac and common iliac arteries with ligation of the external
Table I. Odds ratios for variables potentially associated w
Variable ACS (n  6) No AC
n % n
Female sex 3 50.0 4
Diabetic 1 16.7 5
Smoker 2 33.3 6
Coronary disease 4 66.7 17
Hypertension 3 50.0 19
Pulmonary 0 0 9
Renal 1 16.7 2
Aortic occlusion 4 66.7 3
Mean SD Mean
Age (y) 74.5 7.2 72.9
OR time (min) 89.2 22.5 92.7
Cannulation time (min) 2.8 3.5 2.8
PRBCs (units) 8.2 2.5 1.8
aPTT (s) 128.3 82.0 49.6
ACS, Abdominal compartment syndrome; OR, operating room; PRBCs, piliac via the groin incision or had a covered stent placedfrom the internal into the external artery. In four of six
patients, ACS was diagnosed at the completion of the
endovascular procedure, whereas in two patients ACS was
diagnosed during the postoperative course at 9 and 36
hours, respectively. Bladder pressures were markedly in-
creased to 40 mm Hg or more in patients with ACS, and
laparotomy revealed massive retroperitoneal hematoma
and diffuse bowel edema. Two (50%) of four patients with
an immediate diagnosis of ACS at the completion of the
endovascular procedure survived, but both patients (100%)
with delayed diagnosis died.
DISCUSSION
EVAR of r-AAA is feasible and is associated with im-
proved survival when compared with historical data on
open surgical repair.1-4 In our experience, ACS is a poten-
tial complication after EVAR of r-AAA that can affect up to
20% of patients and can lead to increased morbidity and
mortality. Early recognition of risk factors that contribute
to the development of ACS is imperative in optimizing
treatment and patient outcome. The need for an aortic
occlusion balloon, the presence of severe coagulopathy,
CS
24) P value
Odds
ratio
95% Confidence
interval
% Lower Upper
16.7 .10 5.00 0.73 34.35
20.8 .82 0.76 0.07 8.07
25.0 .68 1.50 0.22 10.36
73.9 .72 0.71 0.10 4.89
82.6 .11 0.21 0.03 1.45
39.1
8.7 .58 2.10 0.16 28.02
12.5 .01 14.00 1.74 112.56
SD
11.9 .74 1.01 0.93 1.10
30.1 .78 1.00 0.96 1.03
2.3 .94 1.01 0.71 1.45
1.6 .08 5.47 0.80 37.20
23.6 .01 1.03 1.01 1.05
red blood cells; aPTT, activated partial thromboplastin time.
Table II. Patients with ACS complicating endovascular
repair of ruptured abdominal aortic aneurysms
Patient
Stent
graft
Time to
ACS
Bladder
pressure
(mm Hg) Outcome
1 Bifurcated OR N/R Alive
2 Bifurcated 9 h 40 Dead
3 AUI OR N/R Dead
4 AUI 36 h 45 Dead
5 AUI OR 45 Dead
6 AUI OR 40 Alive
ACS, Abdominal compartment syndrome; OR, operating room; N/R, not
recorded; AUI, aortouni-iliac device and femorofemoral bypass.ith A
S(n massive transfusion requirements, and the emergent con-
elop
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are variables associated with the development of ACS.
Patients with these risk factors should be monitored closely
for the development of ACS, and those who develop ACS
should undergo immediate abdominal decompression lap-
arotomy.
The pathophysiology of ACS after r-AAA is multifactori-
al.10-13,16 Retroperitoneal hematoma is a space-occupying
lesion and a significant factor contributing to intra-abdominal
hypertension (Fig 2). Presumably, after EVAR, ongoing
bleeding from the lumbar and inferior mesenteric arteries
into the disrupted aneurysm sac in the setting of severe
coagulopathy may contribute to the size of the hematoma.
Furthermore, the shock state associated with r-AAA is
associated with alterations in microvascular permeability
that lead to visceral and soft tissue edema.10-13,16 Patients
with ACS in our series were found to have both massive
retroperitoneal hematoma and diffuse bowel edema at lap-
arotomy. The risk factors for ACS identified in these pa-
tients are markers for perioperative shock, bleeding, and
coagulopathy and are consistent with the defined patho-
physiology. Although the use of an aortic occlusion balloon
was an independent risk factor for development of ACS, in
clinical practice most patients who require the aortic occlu-
sion balloon are those who manifest greater perioperative
shock requiring aggressive resuscitation with blood prod-
ucts and fluids. Furthermore, although preoperative CT
scan was available in 70% of all patients with r-AAA and in
only 50% of patients who developed ACS, this difference
was not statistically significant. Because CT scans were not
available in a significant number of patients, we could not
identify any factors such as mural thrombus, calcifications,
or mesenteric arterial occlusive disease to be associated with
the development of ACS.
Early recognition and treatment of ACS can have a
Fig 2. Computed tomographic scan and illustration of
hematoma and its mass effect that contributes to the devsignificant effect on patient survival. In our experience,delay in diagnosis and treatment of ACS resulted in 100%
mortality, because both patients who were diagnosed with
ACS at 9 and 36 hours after EVAR died. Patients who
underwent immediate on-table laparotomy for a presump-
tive diagnosis of ACS had a survival of 50% (two of four
patients), although this difference was not statistically sig-
nificant. Multisystem organ failure was the cause of death in
all cases. The two survivors with ACS had considerable
postoperative morbidity. One patient developed renal fail-
ure that necessitated permanent dialysis and was unable to
undergo primary abdominal wall closure. He was hospital-
ized for 59 days and required multiple operations and
split-thickness skin grafts to accomplish coverage of the
abdominal contents. The second patient developed isch-
emic colitis that necessitated colectomy and required pro-
longed ventilation with a tracheostomy. He was hospital-
ized for 83 days and underwent delayed primary closure of
the abdominal wall. Both patients are alive and doing well
at 13 months of follow-up. Rasmussen et al12 reported
their findings of a case-control study comparing the out-
comes of open surgical repair of r-AAA in patients requiring
mesh-based abdominal closure because of the presence of
ACS with the outcomes of those with primary abdominal
closure. There findings were similar to ours in that patients
with ACS requiring mesh abdominal closure had more
blood loss and prolonged hypotension and required preop-
erative cardiopulmonary resuscitationmore frequently than
did patients with primary abdominal closure. The patients
with ACS requiring mesh closure had a significantly higher
mortality (56% vs 9%) when compared with patients under-
going primary closure. Furthermore, the mortality from
multiple organ failure increased to 70% when the diagnosis
of ACS and laparotomy were delayed.11-13 We identified
similar variables associated with ACS, all of which are
markers for significant perioperative shock, an important
tured abdominal aortic aneurysm with a retroperitoneal
ment of abdominal compartment syndrome.a ruppredictor of mortality after repair of r-AAA. Of the 24
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than 4 units of blood transfusion, 3 (12%) required an
aortic occlusion balloon, 2 (8%) required emergent conver-
sion to an AUI device, and 1 (4%) had coagulopathy
(activated partial thromboplastin time ratio 1.5). How-
ever, none of these patients had multiple risk factors.
As a result of these observations, our protocol for the
endovascular treatment of r-AAA has evolved. Systemic
heparinization is avoided, and coagulation studies are ag-
gressively corrected during the perioperative period to help
limit the ongoing bleeding from collateral vessels. Further-
more, bladder pressures are recorded on an hourly basis
during the procedure as well as in the postoperative period.
If the bladder pressures are increased, regardless of the
presence of other associated factors, we emphatically rec-
ommend that patients undergo decompression laparot-
omy. However, the question is how many factors need to
be present in the absence of increased bladder pressures to
accurately predict ACS.Only 6 of 30 patients with EVARof
r-AAA developed ACS, and this is too small a number to
have any significant predictive value in a multivariate anal-
ysis. In our clinical practice, after EVAR of r-AAA, regard-
less of the presence of increased bladder pressures, if pa-
tients have more than one risk factor for developing ACS
(aortic occlusion balloon, massive blood transfusion, co-
agulopathy, or conversion to an AUI device), have abdom-
inal distention, and manifest signs of end-organ dysfunc-
tion, they undergo on-table laparotomy. Our findings are
substantiated by other reports in the literature. Veith et al5
and Ohki and Veith6 reported on 30 patients undergoing
EVAR of r-AAA, citing an 11% operative mortality; overt
ACS was diagnosed in 1 surviving patient. Midline laparot-
omy revealed rupture into the peritoneal cavity with hema-
toma and blood in both the intraperitoneal and retroperi-
toneal spaces. Evacuation of the hematoma was performed
prophylactically in two additional surviving patients
through a limited retroperitoneal incision.
In conclusion, the application of endovascular tech-
niques to the treatment of r-AAA offers the potential for
improved outcome. In our experience, ACS develops in a
significant percentage of these patients and has a significant
negative effect on survival. Use of an aortic occlusion
balloon, coagulopathy, massive transfusion, and emergent
conversion to an AUI device are associated with the devel-
opment of ACS in this setting. We recommend that pa-
tients with these risk factors undergo vigilant monitoringfor the development of ACS and that patients who develop
clinical signs of ACS undergo immediate laparotomy.
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